[Abstract] ; [Resumo]
[abstract] ; [resumo]
[abstract] ; [resumo]
[abstract] ; [resumo]
[abstract] ; [resumo]
[abstract] ; [resumo]
[abstract] ; [resumo]
Linezolid, an oxazolidinone-class antimicrobial agent, is a new drug; its use has frequently been questioned due to its high price. However, recent trials have demonstrated that the use of linezolid in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (VAP-MRSA) may be justified due to its improved efficacy compared to vancomycin. Price and cost have di...
Financiadores do RCAAP | |||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |